(HL) Hecla Mining - Ratings and Ratios
Silver, Gold, Lead, Zinc
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.07% |
| Yield on Cost 5y | 0.27% |
| Yield CAGR 5y | -18.91% |
| Payout Consistency | 38.1% |
| Payout Ratio | 5.7% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 63.6% |
| Value at Risk 5%th | 87.9% |
| Relative Tail Risk | -15.97% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 2.51 |
| Alpha | 306.98 |
| CAGR/Max DD | 1.08 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.425 |
| Beta | 0.851 |
| Beta Downside | 0.989 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.18% |
| Mean DD | 21.72% |
| Median DD | 22.38% |
Description: HL Hecla Mining November 07, 2025
Hecla Mining Company (NYSE:HL) is a U.S.-based producer of precious and base metals, operating mines and processing facilities in the United States, Canada, Japan, Korea, and China. Its core assets include the Greens Creek mine in Alaska, which yields silver, gold, lead, and zinc concentrates, as well as carbon material and doré bars for downstream customers.
Key recent metrics: in 2023 Hecla delivered approximately 13.5 million ounces of silver and 70,000 ounces of gold, with a cash cost of roughly $10 per ounce of silver and a net cash flow of $250 million. The balance sheet remains relatively conservative, with total debt of $260 million and a debt-to-cash-flow ratio below 1.0, providing flexibility for capital-intensive projects.
Sector drivers that materially affect Hecla’s outlook include the price of silver, which is influenced by industrial demand (e.g., photovoltaics, electronics) and investment demand tied to real-interest-rate differentials. Additionally, the strength of the U.S. dollar and global inflation expectations can swing silver’s spot price, while lead and zinc markets are sensitive to construction activity and inventory cycles in China.
For a deeper dive into Hecla’s valuation metrics and scenario analysis, the ValueRay platform offers a structured framework you may find useful.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income (309.0m TTM) > 0 and > 6% of Revenue (6% = 73.5m TTM) |
| FCFTA 0.07 (>2.0%) and ΔFCFTA 9.64pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 16.95% (prev 2.07%; Δ 14.88pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.13 (>3.0%) and CFO 413.1m > Net Income 309.0m (YES >=105%, WARN >=100%) |
| Net Debt (155.8m) to EBITDA (527.6m) ratio: 0.30 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (671.9m) change vs 12m ago 7.38% (target <= -2.0% for YES) |
| Gross Margin 36.12% (prev 16.26%; Δ 19.86pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 39.65% (prev 28.45%; Δ 11.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 7.24 (EBITDA TTM 527.6m / Interest Expense TTM 49.8m) >= 6 (WARN >= 3) |
Altman Z'' 0.68
| (A) 0.06 = (Total Current Assets 387.5m - Total Current Liabilities 180.0m) / Total Assets 3.22b |
| (B) -0.10 = Retained Earnings (Balance) -313.9m / Total Assets 3.22b |
| (C) 0.12 = EBIT TTM 360.7m / Avg Total Assets 3.09b |
| (D) -0.20 = Book Value of Equity -153.2m / Total Liabilities 772.2m |
| Total Rating: 0.68 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 83.83
| 1. Piotroski 7.50pt |
| 2. FCF Yield 1.85% |
| 3. FCF Margin 19.62% |
| 4. Debt/Equity 0.12 |
| 5. Debt/Ebitda 0.30 |
| 6. ROIC - WACC (= 8.98)% |
| 7. RoE 13.93% |
| 8. Rev. Trend 78.54% |
| 9. EPS Trend 45.98% |
What is the price of HL shares?
Over the past week, the price has changed by +14.26%, over one month by +40.50%, over three months by +78.64% and over the past year by +336.84%.
Is HL a buy, sell or hold?
- Strong Buy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the HL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 15.9 | -28.6% |
| Analysts Target Price | 15.9 | -28.6% |
| ValueRay Target Price | 25.4 | 14% |
HL Fundamental Data Overview January 03, 2026
P/E Trailing = 61.9032
P/E Forward = 26.6667
P/S = 10.501
P/B = 5.2495
P/EG = -3.02
Beta = 1.355
Revenue TTM = 1.22b USD
EBIT TTM = 360.7m USD
EBITDA TTM = 527.6m USD
Long Term Debt = 269.8m USD (from longTermDebt, last quarter)
Short Term Debt = 9.98m USD (from shortTermDebt, last quarter)
Debt = 289.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 155.8m USD (from netDebt column, last quarter)
Enterprise Value = 13.01b USD (12.86b + Debt 289.7m - CCE 133.9m)
Interest Coverage Ratio = 7.24 (Ebit TTM 360.7m / Interest Expense TTM 49.8m)
FCF Yield = 1.85% (FCF TTM 240.3m / Enterprise Value 13.01b)
FCF Margin = 19.62% (FCF TTM 240.3m / Revenue TTM 1.22b)
Net Margin = 25.23% (Net Income TTM 309.0m / Revenue TTM 1.22b)
Gross Margin = 36.12% ((Revenue TTM 1.22b - Cost of Revenue TTM 782.2m) / Revenue TTM)
Gross Margin QoQ = 44.07% (prev 39.31%)
Tobins Q-Ratio = 4.04 (Enterprise Value 13.01b / Total Assets 3.22b)
Interest Expense / Debt = 4.63% (Interest Expense 13.4m / Debt 289.7m)
Taxrate = -35.27% (negative due to tax credits) (-54.9m / 155.6m)
NOPAT = 487.9m (EBIT 360.7m * (1 - -35.27%)) [negative tax rate / tax credits]
Current Ratio = 2.15 (Total Current Assets 387.5m / Total Current Liabilities 180.0m)
Debt / Equity = 0.12 (Debt 289.7m / totalStockholderEquity, last quarter 2.45b)
Debt / EBITDA = 0.30 (Net Debt 155.8m / EBITDA 527.6m)
Debt / FCF = 0.65 (Net Debt 155.8m / FCF TTM 240.3m)
Total Stockholder Equity = 2.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.59% (Net Income 309.0m / Total Assets 3.22b)
RoE = 13.93% (Net Income TTM 309.0m / Total Stockholder Equity 2.22b)
RoCE = 14.50% (EBIT 360.7m / Capital Employed (Equity 2.22b + L.T.Debt 269.8m))
RoIC = 18.07% (NOPAT 487.9m / Invested Capital 2.70b)
WACC = 9.09% (E(12.86b)/V(13.15b) * Re(9.15%) + D(289.7m)/V(13.15b) * Rd(4.63%) * (1-Tc(-0.35)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 4.91%
[DCF Debug] Terminal Value 65.61% ; FCFE base≈240.3m ; Y1≈157.7m ; Y5≈72.1m
Fair Price DCF = 1.77 (DCF Value 1.19b / Shares Outstanding 670.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 45.98 | EPS CAGR: -6.46% | SUE: -4.0 | # QB: 0
Revenue Correlation: 78.54 | Revenue CAGR: 23.59% | SUE: 4.0 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.20 | Chg30d=-0.015 | Revisions Net=+2 | Analysts=2
EPS next Year (2026-12-31): EPS=0.76 | Chg30d=-0.013 | Revisions Net=+0 | Growth EPS=+102.3% | Growth Revenue=+14.7%
Additional Sources for HL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle